
Cosomil, Inc. is an innovative start-up dedicated to advancing early cancer detection through the development of blood-based tests. Our groundbreaking technology, known as Single Enzyme Activity-based Protein Profiling, enables ultra-sensitive detection of enzyme activity at the single molecule level using state-of-the-art fluorescent probes and microdevices.
Annual Revenue$1M to $5M
Estimated OwnershipPrivateBuilt from contact records that share this company: name, job title, job level, job function and person location.
Turn cold outreach into meaningful business conversations.
Rated and recommended by professionals who expect more
Matching runs on fields we already have: industry, employee range, HQ location, ownership type, funding rounds, specialities. Results come live from the ReachStream directory.